PlainRecalls
CriticalClass ITerminated

FDA Devices recall · Reported July 7, 2021

LeadCare Plus Blood Lead Test Kit Catalog Number 82-0004

Magellan has received reports that control tests of either the Low-Control and/or the High-Control generated a low result. The issue may cause the underestimation of blood lead le…

Recall #
Z-1953-2021
Affected scope
320 kits (96 tests/kit=30,720 tests)
Initiated
May 7, 2021
Verify with FDA Devices →
View my saved recalls

Magellan Diagnostics, Inc. recalled LeadCare Plus Blood Lead Test Kit Catalog Number 82-0004 - a critical-severity action.

LeadCare Plus Blood Lead Test Kit Catalog Number 82-0004 was recalled by Magellan Diagnostics, Inc. in July 7, 2021. Reason: Magellan has received reports that control tests of either the Low-Control and/or the High-Control generated …. Check the official notice for the remedy. Verify recall #Z-1953-2021 with the FDA Devices before acting.

The recall

Magellan Diagnostics, Inc. issued this critical-severity FDA Devices recall-Magellan has received reports that control tests of either the Low-Control and/or the High-Control generated ….

Critical
severity level
Class I
classification
July 7, 2021
reported

Sourced from official FDA Devices enforcement records. Verify recall #Z-1953-2021 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Medical Devices recalls over time

Where this recall sits in its category - 41,021 medical devices recalls on record

01,0002,0003,0004,000 20052008201120142017202020232026 1,947
Severity1906864652High severity (most serious)Moderate severityLow severity
Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified high severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

LeadCare Plus Blood Lead Test Kit Catalog Number 82-0004

Reason for recall

Magellan has received reports that control tests of either the Low-Control and/or the High-Control generated a low result. The issue may cause the underestimation of blood lead levels in patient samples.

Recall Profile

Structured summary of the FDA Devices recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Critical (Class I)
Status Terminated
Recall number Z-1953-2021
Date reported July 7, 2021
Date initiated May 7, 2021
Recalling firm Magellan Diagnostics, Inc.
Firm location North Billerica, MA
Affected scope 320 kits (96 tests/kit=30,720 tests)
Distribution Worldwide distribution. US nationwide including Puerto Rico; Canada, Vietnam, India, Italy, Peru, New Zealand, Australia, Hong Kong, and Philippines.

Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (Z-1953-2021) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Devices before acting, recall details can be updated.
  • This is a Class I (high-risk) recall, stop using the product immediately and follow the disposal or return instructions. What to do next

This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
LeadCare Plus Blood Lead Test Kit Catalog Number 82-0004. Recalled by Magellan Diagnostics, Inc.. Units affected: 320 kits (96 tests/kit=30,720 tests).
Why was this product recalled?
Magellan has received reports that control tests of either the Low-Control and/or the High-Control generated a low result. The issue may cause the underestimation of blood lead levels in patient samples.
Which agency issued this recall?
This recall was issued by the FDA Devices on July 7, 2021. Severity: Critical. Recall number: Z-1953-2021.
Where was the recalled product distributed?
Distribution: Worldwide distribution. US nationwide including Puerto Rico; Canada, Vietnam, India, Italy, Peru, New Zealand, Australia, Hong Kong, and Philippines..
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Compare this recall with GORE VIABIL Short Wire Biliary Endoprosthesis, Model No. VS… → · All Medical Devices recalls

This recall: FDA Devices, reported July 7, 2021. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026